spacer
home > ict > spring 2019 > the patient data paradigm
PUBLICATIONS
International Clinical Trials

The Patient Data Paradigm

Translational research, multifaceted collaboration, and nextgeneration trial designs are helping to progress the reality of precision medicine in cancer treatment. Patient data − in particular, genomic data and pharmacogenomic data − have become the centre point of research. However, unless we remember to view patient contribution in medical research with the patient’s interest at heart, we may risk failing in the attempt to implement precious patient data effectively.

Cancer therapy has seen one of the most revolutionary transformations in decades. A deeper understanding of the disease at a molecular level has shifted the cancer treatment paradigm, and personalised cancer medicines are now promising to deliver the right drug to the right person at the right time, tackling tumour behaviour with precise mechanisms of action.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Dr Aldo Poli has over 30 years’ experience in the pharma industry, with a deep expertise in methodology and statistics. He is co-founder and CEO of OPIS, a full service CRO founded in 1998 that focuses on clinical trial management for multicountry Phase 1-4 trials, non-interventional studies, and medical device investigations.
spacer
Dr Aldo Poli
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma Celebrates 15 Years of Growth and Success

Vilnius, Lithuania, July 16, 2019 ─ Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company focuses on understanding its customers and meeting their specific needs without binding them to one single approach. It is able to react rapidly to unexpected project changes, adjusting timelines, capacities and other activities to meet its customers’ evolving needs. On average, Northway Biotechpharma has 25–30 development projects underway each year, ranging from gene cloning to final drug product manufacturing.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement